Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Semintra Oral Solution for Cats Recalled for Incorrect pH and Particles

Agency Publication Date: July 7, 2023
Share:
Sign in to monitor this recall

Summary

Boehringer Ingelheim Animal Health USA Inc. has recalled 13,242 bottles of Semintra (telmisartan oral solution) 10 mg/mL, a medication used for cats. This recall was initiated because the product was found to be outside of its required pH specifications and showed the formation of particles (precipitation). If you have this medication, you should consult your veterinarian regarding your cat's health and stop using the affected batches immediately.

Risk

The medication's chemical balance (pH) is incorrect and solid particles have formed in the solution, which may compromise the drug's effectiveness or safety when administered to cats.

What You Should Do

  1. Check the label of your Semintra (telmisartan oral solution) 35 mL bottle for batches D49253 or D67319, both with an expiration date of September 2023.
  2. If you have animal health concerns, contact your veterinarian.
  3. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer or supplier for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: If you have animal health concerns, contact your veterinarian. Return any unused product to the place of purchase for a refund, or contact the manufacturer or supplier for further instructions
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away.

Affected Products

Product: Semintra (telmisartan oral solution) 10 mg/mL (35 mL)
Variants: 10 mg/mL, For oral use in cats only
UPC Codes:
012313449216
Lot Numbers:
D49253 (Exp. Sept. 2023)
D67319 (Exp. Sept. 2023)
NDC:
0010-4492-01

Recall #: V-0149-2023; Marketed by Boehringer Ingelheim Animal Health USA Inc.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 92631
Status: Resolved
Manufacturer: Boehringer Ingelheim Animal Health USA Inc
Sold By: Veterinary clinics; Animal pharmacies
Manufactured In: United States
Units Affected: 13,242 bottles
Distributed To: Nationwide
Agency Last Updated: July 19, 2023

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response